On September 7, 2021 Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, reported that Douglas E. Onsi, President and Chief Executive Officer, will participate in two upcoming virtual investor conferences (Press release, Leap Therapeutics, SEP 7, 2021, View Source [SID1234587354]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright 23rd Annual Global Investment Conference
Date: Monday, September 13. 2021
Time: 7:00 a.m. ET

Baird 2021 Global Healthcare Conference
Date: Wednesday, September 15, 2021
Time: 3:10 p.m. ET

A live webcast of the Baird fireside chat and a replay of the pre-recorded H.C. Wainwright presentation may be accessed on the Investors page of the company’s website at View Source, where a replay of the events will also be available for a limited time.

On September 7, 2021 Elevation Oncology, Inc. (Nasdaq: ELEV), a clinical stage biopharmaceutical company focused on the development of precision medicines for patients with genomically defined cancers, reported that Shawn M. Leland, PharmD, Rph, Founder and Chief Executive Officer of Elevation Oncology, will present virtually at the H.C. Wainwright 23rd Annual Global Investment Conference (Press release, Elevation Oncology, SEP 7, 2021, https://www.prnewswire.com/news-releases/elevation-oncology-to-present-at-the-hc-wainwright-23rd-annual-global-investment-conference-301369354.html [SID1234587353]). The presentation will be available on demand starting at 7:00 a.m. ET on Monday, September 13, 2021.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A webcast of the event will be accessible for 30 days on the Events page of the Company’s Investor Relations website at View Source

On September 7, 2021 Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, reported that the Company will participate in the following upcoming virtual investor conferences (Press release, Poseida Therapeutics, SEP 7, 2021, View Source [SID1234587352]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H. C. Wainwright 23rd Annual Global Investment Conference
Date: On-demand session opens Monday, September 13, 2021
Time: 7:00am ET

Cantor Fitzgerald Global Healthcare Conference
Date: Monday, September 27, 2021
Time: 8:40am ET

Webcasts will be available on the Investors & Media Section of the Poseida website, www.poseida.com. An archived replay of each webcast will be available for approximately 30 days following each presentation.

On September 7, 2021 Viracta Therapeutics, Inc. (NASDAQ: VIRX), a precision oncology company targeting virus-associated malignancies, reported that company management will present and be available for virtual one-on-one meetings at the H.C. Wainwright 23rd Annual Global Investment Conference, September 13 – 15, 2021, the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit, September 20 – 23, 2021, and the 2021 Cantor Virtual Global Healthcare Conference, September 27 – 30, 2021 (Press release, Viracta Therapeutics, SEP 7, 2021, View Source [SID1234587351]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details on the presentations can be found below.

H.C. Wainwright 23rd Annual Global Investment Conference

Presentation Date:

Corporate presentation will be available on-demand to conference
registrants starting at 7:00 AM ET on September 13, 2021

Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

Presentation Date:

September 21, 2021

Presentation Time:

4:35 PM ET

Format:

Corporate presentation

Webcast Link:

View Source

2021 Cantor Virtual Global Healthcare Conference

Presentation Date:

September 30, 2021

Presentation Time:

8:40 AM ET

Format:

Corporate presentation

A replay of the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit presentation will be available on the "Events and Webcasts" section of the Viracta website at View Source

On September 7, 2021 Aethlon Medical, Inc. (Nasdaq: AEMD), a medical technology company focused on developing products to diagnose and treat life and organ threatening diseases, reported that it will be presenting at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference (Press release, Aethlon Medical, SEP 7, 2021, https://www.prnewswire.com/news-releases/aethlon-medical-to-present-at-the-hc-wainwright-23rd-annual-global-investment-conference-301370027.html [SID1234587350]). The conference is being held virtually from September 13-15, 2021.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Charles J. Fisher, M.D., Chief Executive Officer, will present an overview of Aethlon Medical the conference. The presentation will be available on-demand beginning Monday, September 13 at 7:00 AM EDT at the link below and will be archived for 90 days. It will also be available on the Aethlon website. In addition to the overview presentation, Dr. Fisher will be hosting virtual one-on-one meetings at the conference on Monday, September 13.

Event: H.C. Wainwright 23rd Annual Global Investment Conference (Virtual Conference)

Date: September 13, 2021

Time: 7:00 AM EDT

Location: Virtual Conference

Company Webcasting Link: View Source